Detailed information for compound 1340516

Basic information

Technical information
  • TDR Targets ID: 1340516
  • Name: 4-(1,3-benzodioxol-5-yl)-1-(4-fluorophenyl)su lfonylpiperidin-4-ol
  • MW: 379.403 | Formula: C18H18FNO5S
  • H donors: 1 H acceptors: 3 LogP: 2.14 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1ccc(cc1)S(=O)(=O)N1CCC(CC1)(O)c1ccc2c(c1)OCO2
  • InChi: 1S/C18H18FNO5S/c19-14-2-4-15(5-3-14)26(22,23)20-9-7-18(21,8-10-20)13-1-6-16-17(11-13)25-12-24-16/h1-6,11,21H,7-10,12H2
  • InChiKey: CJNYSNNQEYIOAH-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 4-(1,3-benzodioxol-5-yl)-1-(4-fluorophenyl)sulfonyl-piperidin-4-ol
  • 4-(1,3-benzodioxol-5-yl)-1-(4-fluorophenyl)sulfonyl-4-piperidinol
  • ASN 07829432
  • ZINC04383547
  • 4-Benzo[1,3]dioxol-5-yl-1-(4-fluoro-benzenesulfonyl)-piperidin-4-ol
  • MLS000034054
  • SMR000008121

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens TAR DNA binding protein Starlite/ChEMBL No references
Influenza A virus Nonstructural protein 1 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) RNA binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Brugia malayi TAR-binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Schistosoma mansoni tar DNA-binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Schistosoma mansoni tar DNA-binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Schistosoma japonicum TAR DNA-binding protein 43, putative Get druggable targets OG5_132461 All targets in OG5_132461
Brugia malayi RNA recognition motif domain containing protein Get druggable targets OG5_132461 All targets in OG5_132461
Schistosoma mansoni tar DNA-binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Schistosoma mansoni tar DNA-binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Echinococcus multilocularis tar DNA binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein Get druggable targets OG5_132461 All targets in OG5_132461
Schistosoma japonicum TAR DNA-binding protein 43, putative Get druggable targets OG5_132461 All targets in OG5_132461
Echinococcus granulosus tar DNA binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Loa Loa (eye worm) TAR-binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Schistosoma mansoni tar DNA-binding protein Get druggable targets OG5_132461 All targets in OG5_132461
Brugia malayi RNA binding protein Get druggable targets OG5_132461 All targets in OG5_132461
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium tuberculosis Hypothetical protein Nonstructural protein 1   230 aa 202 aa 23.8 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Giardia lamblia NADPH oxidoreductase, putative 0.0166 1 0.5
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Giardia lamblia NADPH oxidoreductase, putative 0.0166 1 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0166 1 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 15.8489 uM PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 19.9526 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 31.6228 um PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 35.4813 um PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.